Interagency Patent Coordination and Improvement Act of 2025
Click any stage to learn more about the legislative process.
Topic: Commerce
Sponsor: Sen. Durbin, Richard J. [D-IL] (D) - IL
Summary
This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products.
The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the USPTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the USPTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the USPTO, and (3) the USPTO to assist the FDA in its ministerial role of listing patents.
Legislative Subjects
Administrative remedies; Commerce; Department of Commerce; Drug safety, medical device, and laboratory regulation; Food and Drug Administration (FDA); Intellectual property; Intergovernmental relations
Latest Action
Placed on Senate Legislative Calendar under General Orders. Calendar No. 41.
2025-04-10
Ask about this bill
Ask questions about this bill. The AI can look up referenced laws and statutes to provide context.
What existing laws does this bill amend?
What are the main provisions of this bill?
Who would be affected by this legislation?